News from NYU Langone Health
Empowered Patient Podcast
NYU Langone Health has implemented an "About Me" initiative within its electronic health record system to foster stronger connections between patients and care teams. The program was envisioned by Katherine Hochman, MD, director of the Division of Hospital Medicine at NYU Grossman School of Medicine, and created with the help of Paul Testa, MD, chief health informatics officer at NYU Langone Health. The initiative provides a dedicated space in the patient's chart for them to share non-medical information like hobbies and interests. Dr. Testa explained that this allows care teams to see patients as whole people beyond their diagnoses. Dr. Hochman, a hospitalist, noted that as hospital stays get shorter, there is less time to connect. The "About Me" section helps "kick off that connection" and build trust quickly. The initiative is now expanding from inpatient to outpatient settings.
2/17/2026
Becker's Hospital Review
As patients increasingly use AI for health information, health systems are shifting their marketing strategies to focus on credibility rather than traffic volume. According to Elizabeth Golden, executive vice president for communications, marketing, government and community affairs at NYU Langone Health, the system is 'laser-focused on showing up as a trusted and authoritative source' within AI platforms. Golden added that the goal is to ensure AI tools recognize NYU Langone Health as a leading clinical authority, so it remains a top destination that patients trust and choose for their healthcare decisions.
2/19/2026
New York Post
Daniel J. Kaplan, MD, a sports orthopedic surgeon with NYU Langone Health, joins 'The Injury Report' to discuss New York Yankees shortstop Anthony Volpe's recovery from a partially torn labrum. Dr. Kaplan analyzes whether Volpe risked long-term impacts by playing through the injury during the 2025 season. The segment provides a sports orthopedic surgeon's perspective on the player's condition and recovery process.
2/19/2026
Real Simple
Experts across 12 fields shared their top advice for living a long, healthy life, including strength training, daily SPF use, and maintaining social connections. Dana R. Gossett, MD, chair of the Department of Obstetrics and Gynecology at NYU Grossman School of Medicine, highlighted the importance of strength training and cardiovascular exercise for women during menopause. She explained that muscle mass helps lower the increased risk of diabetes and osteoporosis associated with this phase of life. Other recommendations include flossing, wearing comfortable shoes, and eating more fiber.
Also reporting was: ,
2/19/2026
Women's Health
An article addressing the myth that running is bad for knees features expert commentary from Abigail A. Campbell, MD, orthopedic sports surgeon and director of the Center for Women's Sports Health at NYU Langone Health. She calls this belief a 'dated notion,' emphasizing that weight-bearing exercise is necessary for joint health. Dr. Campbell explains that bone and cartilage remodel and strengthen in response to compression, and without such impact, bone density decreases and cartilage weakens. The article also cites recent research disproving a link between running and arthritis and provides tips for maintaining knee health.
Also reporting was: ,
2/19/2026
Clinical Correlations
In a peer-reviewed article, Joshua Wang, a Class of 2027 medical student at NYU Grossman School of Medicine, explores the potential of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) like semaglutide for treating alcohol use disorder (AUD). The piece reviews preclinical and clinical evidence, including a Phase II trial where semaglutide reduced heavy drinking days and cravings. The author notes that GLP-1 RAs, known for treating diabetes and obesity, may work by dampening the brain's reward signals. The article also discusses ongoing research into their use for other addictions and addresses psychiatric safety concerns.
2/19/2026
MedicalResearch.com
A study from researchers at NYU Grossman School of Medicine outlines how melanoma tumors sustain their blood supply and evade immune detection. According to Pietro Berico, M.Sc., Ph.D., a postdoctoral research fellow at NYU Grossman School of Medicine and NYU Langone's Perlmutter Cancer Center, the team identified the transcription factor HOXD13 as being consistently upregulated in immune-cold tumors. HOXD13 orchestrates a gene program that remodels blood vessels and helps melanoma cells escape the immune response. The findings suggest that tumors with high levels of HOXD13 may be particularly sensitive to a novel therapeutic combination of Lenvatinib and Etrumadenant.
2/19/2026
